Cassidy E Tierney1, Mary Kathryn Abel2, Mubarika M Alavi3, Miranda Ritterman Weintraub4, Andrew Avins3, Eve Zaritsky1. 1. Department of Obstetrics and Gynecology, Kaiser Permanente Northern California, Oakland, CA, USA. 2. University of California, San Francisco, School of Medicine, San Francisco, CA, USA. 3. Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA. 4. Department of Graduate Medical Education, Kaiser Permanente Northern California, Oakland, CA, USA.
Abstract
OBJECTIVE: COVID-19 has had an unprecedented impact on medical care use and delivery, including stark reductions in emergency department (ED) volume. The aim of this study was to assess changes in incidence of OB/GYN ED visits and disease severity at time of presentation during the COVID-19 pandemic. STUDY DESIGN: We conducted a multicenter retrospective study of OB/GYN-related ED visits before and during the COVID-19 pandemic. Incidence rates (IRs) and severity measures were compared across time periods and years. RESULTS: A total of 18,668 OB/GYN ED encounters occurred between January 1 and December 31, 2020, compared to 21,014 encounters between January 1 and December 31, 2019. During shelter-in-place, visits decreased by 41% compared to the pre-pandemic period in 2020 before returning to typical rates (incidence rate ratio (IRR) = 0.98 in fall/winter). We found a similar proportion of patients with hemoglobin < 7 g/dL for diagnoses associated with bleeding and patients with white blood cell count > 12,000 per µL in the setting of infection comparing corresponding time periods in 2019 and 2020. There were fewer formal OB/GYN consults, hospital admissions at time of presentation, and urgent surgical procedures performed across all periods in 2020; however, hospitalization within 7 days substantially increased in the first half of 2020. CONCLUSION: The incidence of OB/GYN ED visits declined substantially between March and August 2020 but then returned to pre-pandemic levels by fall/winter 2020. The decreased incidence was not accompanied by an increase in severity of presentation.
OBJECTIVE: COVID-19 has had an unprecedented impact on medical care use and delivery, including stark reductions in emergency department (ED) volume. The aim of this study was to assess changes in incidence of OB/GYN ED visits and disease severity at time of presentation during the COVID-19 pandemic. STUDY DESIGN: We conducted a multicenter retrospective study of OB/GYN-related ED visits before and during the COVID-19 pandemic. Incidence rates (IRs) and severity measures were compared across time periods and years. RESULTS: A total of 18,668 OB/GYN ED encounters occurred between January 1 and December 31, 2020, compared to 21,014 encounters between January 1 and December 31, 2019. During shelter-in-place, visits decreased by 41% compared to the pre-pandemic period in 2020 before returning to typical rates (incidence rate ratio (IRR) = 0.98 in fall/winter). We found a similar proportion of patients with hemoglobin < 7 g/dL for diagnoses associated with bleeding and patients with white blood cell count > 12,000 per µL in the setting of infection comparing corresponding time periods in 2019 and 2020. There were fewer formal OB/GYN consults, hospital admissions at time of presentation, and urgent surgical procedures performed across all periods in 2020; however, hospitalization within 7 days substantially increased in the first half of 2020. CONCLUSION: The incidence of OB/GYN ED visits declined substantially between March and August 2020 but then returned to pre-pandemic levels by fall/winter 2020. The decreased incidence was not accompanied by an increase in severity of presentation.
Authors: Matthew D Solomon; Edward J McNulty; Jamal S Rana; Thomas K Leong; Catherine Lee; Sue-Hee Sung; Andrew P Ambrosy; Stephen Sidney; Alan S Go Journal: N Engl J Med Date: 2020-05-19 Impact factor: 91.245
Authors: Hendrik Borgmann; Julian P Struck; Angelika Mattigk; Mike Wenzel; Adrian Pilatz; Jennifer Kranz; Richard Weiten; Nicolas von Landenberg; Philipp Julian Spachmann; Cem Aksoy; Axel Haferkamp; Katharina Boehm Journal: Urol Int Date: 2021-01-06 Impact factor: 2.089
Authors: Stanley Xu; Sungching Glenn; Lina Sy; Lei Qian; Vennis Hong; Denison S Ryan; Steven Jacobsen Journal: J Med Internet Res Date: 2021-04-17 Impact factor: 5.428
Authors: Catalina Bover-Bauza; Maria Antonia Rosselló Gomila; David Díaz Pérez; Aina Rosa Millán Pons; Jose Antonio Gil Sánchez; Jose Antonio Peña-Zarza; Joan Figuerola Mulet; Borja Osona Journal: J Asthma Allergy Date: 2021-02-03
Authors: Santiago Garcia; Mazen S Albaghdadi; Perwaiz M Meraj; Christian Schmidt; Ross Garberich; Farouc A Jaffer; Simon Dixon; Jeffrey J Rade; Mark Tannenbaum; Jenny Chambers; Paul P Huang; Timothy D Henry Journal: J Am Coll Cardiol Date: 2020-04-10 Impact factor: 24.094
Authors: Jason C Fisher; Sandra S Tomita; Howard B Ginsburg; Alex Gordon; David Walker; Keith A Kuenzler Journal: Ann Surg Date: 2021-03-01 Impact factor: 13.787